United States Antimony (NYSE:UAMY – Get Free Report) was upgraded by analysts at Wall Street Zen from a “strong sell” rating to a “sell” rating in a report issued on Saturday, Wall Street Zen reports.
Other equities research analysts have also recently issued reports about the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of United States Antimony in a research report on Monday, September 14th. Texas Capital upgraded shares of United States Antimony to a “strong-buy” rating in a research note on Wednesday, October 7th. Finally, HC Wainwright dropped their price objective on United States Antimony from $9.25 to $6.50 and set a “buy” rating on the stock in a report on Friday. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, United States Antimony has an average rating of “Moderate Buy” and an average target price of $8.75.
Read Our Latest Report on United States Antimony
United States Antimony Trading Up 1.0%
Shares of NYSE:UAMY opened at $3.12 on Friday. The company has a market capitalization of $467.27 million, a PE ratio of -20.81 and a beta of 0.49. United States Antimony has a twelve month low of $2.53 and a twelve month high of $12.64. The firm has a 50 day simple moving average of $3.77 and a 200-day simple moving average of $6.89.
United States Antimony (NYSE:UAMY – Get Free Report) last issued its earnings results on Thursday, November 12th. The company reported ($0.06) earnings per share (EPS) for the quarter. The company had revenue of $10.13 million during the quarter. United States Antimony had a negative net margin of 55.44% and a negative return on equity of 7.48%. As a group, equities research analysts predict that United States Antimony will post -0.01 EPS for the current fiscal year.
Insider Buying and Selling
In other United States Antimony news, Director Joseph A. Carrabba acquired 21,300 shares of the stock in a transaction on Tuesday, September 1st. The shares were bought at an average cost of $4.72 per share, with a total value of $100,536.00. Following the transaction, the director owned 198,401 shares of the company’s stock, valued at approximately $936,452.72. This trade represents a 12.03% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Gary C. Evans acquired 20,000 shares of the company’s stock in a transaction on Friday, August 28th. The stock was acquired at an average price of $4.92 per share, for a total transaction of $98,400.00. Following the completion of the purchase, the chief executive officer owned 2,590,028 shares of the company’s stock, valued at $12,742,937.76. This trade represents a 0.78% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired a total of 62,700 shares of company stock worth $298,592 in the last 90 days. Company insiders own 5.50% of the company’s stock.
Institutional Investors Weigh In On United States Antimony
Several hedge funds have recently made changes to their positions in UAMY. KBC Group NV purchased a new position in shares of United States Antimony during the first quarter worth about $31,000. Farther Finance Advisors LLC increased its position in United States Antimony by 65.2% in the 3rd quarter. Farther Finance Advisors LLC now owns 8,545 shares of the company’s stock valued at $36,000 after acquiring an additional 3,372 shares during the period. Axxcess Wealth Management LLC purchased a new stake in United States Antimony during the 3rd quarter valued at approximately $44,000. Inscription Capital LLC purchased a new stake in United States Antimony during the 3rd quarter valued at approximately $47,000. Finally, Wealthfront Advisers LLC purchased a new stake in United States Antimony during the 2nd quarter valued at approximately $85,000. Institutional investors and hedge funds own 9.49% of the company’s stock.
Key Stories Impacting United States Antimony
Here are a few of the latest stories about UAMY:
- Positive Sentiment: Third-quarter revenue rose 16% year over year, to $10.13 million, providing evidence of top-line growth. Read More.
- Neutral Sentiment: HC Wainwright kept its Buy rating but cut its price target from $9.25 to $6.50. The revised target still indicates substantial potential upside from the cited $3.12 price, but the reduction reflects a more cautious outlook. Read More.
- Negative Sentiment: UAMY reported a third-quarter loss of $0.06 per share, wider than the $0.02 loss analysts expected and the $0.04 loss a year earlier. Revenue also missed estimates, while the company’s withdrawal of guidance added uncertainty. These factors were cited in reports of an overnight share decline. Read More. · Read More.
About United States Antimony
United States Antimony Corporation mines, processes and sells antimony and related products. Its offerings include antimony oxide, antimony metal and sodium antimonate, materials used in a range of industrial applications. The company also produces zeolite through its Bear River Zeolite operations in Idaho. Zeolite products are used in applications such as water treatment, agriculture and odor control. Founded in 1968, United States Antimony has processing operations in Montana and Mexico, as well as zeolite operations in Idaho.
Further Reading
- Five stocks we like better than United States Antimony
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for United States Antimony Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United States Antimony and related companies with MarketBeat.com's FREE daily email newsletter.
